IMMP vs CBIO
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Oct 23, 2026
IMMP
CBIO
Investment Advisor Scores
CBIO
AI Analyst Insights
Detailed Metrics Comparison
| Metric | IMMP | CBIO | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 7.1327 | 0 | Tie |
| PEG Ratio | 0 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 633.5% | 0.0% | IMMP |
| Earnings Growth | 0.0% | 0.0% | Tie |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 33.7/100 | 52.3/100 | CBIO |
| Profit Margin | 0.0% | 0.0% | Tie |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | AVOID NEW MONEY | HOLD | CBIO |
Relative Price Performance (Last 90 Days)
Current Technical Phase
IMMP
MarkupPrice above SMA50, rising 50-day trend (375.7% over 20 days), RSI 58
CBIO
MarkdownPrice below a falling SMA50 (slope -5.8%), weak momentum, RSI 39
Fundamentals Snapshot
| Metric | IMMP | CBIO |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | -12.3 | -4.9 |
| Trailing P/E | — | — |
| Revenue (TTM) | — | — |
| Revenue Growth | 6.3% | 0.0% |
| Gross Margin | -3.6% | 1.0% |
| Operating Margin | -2.6% | -14.3% |
| EPS | -7.11 | -7.62 |
| Dividend Yield | — | — |